UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 192

Sortiert nach

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Journal of cancer research and clinical oncology, 2023-03, Vol.149 (3), p.1195-1209

2023

Link zum Volltext

Verfügbarkeit prüfen

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Leukemia, 2009-06, Vol.23 (6), p.1054-1061

2009

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

Cancer, 2009-02, Vol.115 (3), p.551-560

2009

Link zum Volltext

Verfügbarkeit prüfen

High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

Annals of oncology, 2010-11, Vol.21 (11), p.2255-2261

2010

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

Annals of oncology, 2009-10, Vol.20 (10), p.1667-1673

2009

Link zum Volltext

Verfügbarkeit prüfen

Cetuximab plus oxaliplatin leucovorin 5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

British journal of cancer, 2010-02, Vol.102 (3), p.500-505

2010

Link zum Volltext

Verfügbarkeit prüfen

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Clinical cancer research, 2009-01, Vol.15 (2), p.460-467

2009

Link zum Volltext

Verfügbarkeit prüfen

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Annals of oncology, 2003-10, Vol.14 (10), p.1570-1577

2003

Link zum Volltext

Verfügbarkeit prüfen

Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use

Journal of clinical oncology, 2003-07, Vol.21 (14), p.2651-2657

2003

Link zum Volltext

Verfügbarkeit prüfen

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

Journal of clinical oncology, 2009-06, Vol.27 (17), p.2823-2830

2009

Link zum Volltext

Verfügbarkeit prüfen

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Leukemia, 2013-06, Vol.27 (6), p.1416-1418

2013

Link zum Volltext

Verfügbarkeit prüfen

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer

The lancet oncology, 2003-04, Vol.4 (4), p.233-241

2003

Link zum Volltext

Verfügbarkeit prüfen

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

Breast cancer research : BCR, 2017-10, Vol.19 (1), p.112-112, Article 112

2017

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Annals of oncology, 2008-08, Vol.19 (8), p.1450-1457

2008

Link zum Volltext

Verfügbarkeit prüfen

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Leukemia, 2016-01, Vol.30 (1), p.112-123

2016

Link zum Volltext

Verfügbarkeit prüfen

Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model

Oncogene, 2015-01, Vol.34 (5), p.578

2015

Link zum Volltext

Verfügbarkeit prüfen

Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in the Management of Locally Advanced or Aggressive Prostate Adenocarcinoma

International journal of radiation oncology, biology, physics, 2009-12, Vol.75 (5), p.1344-1349

2009

Link zum Volltext

Verfügbarkeit prüfen

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Annals of oncology, 2007-10, Vol.18 (10), p.1673-1679

2007

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Journal of clinical oncology, 2009-09, Vol.27 (25), p.4068-4075

2009

Link zum Volltext

Verfügbarkeit prüfen

Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors

Oncogene, 2015-08, Vol.34 (33), p.4347-4357

2015

Link zum Volltext

Verfügbarkeit prüfen

The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor Kinase Inhibitors

Journal of thoracic oncology, 2011-02, Vol.6 (2), p.387-392

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(184)
Mit Volltextzugriff
(177)

Publikationsform

Artikel
(192)

Sprache

Englisch
(191)
Japanisch
(38)
Russisch
(2)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(186)
Life Sciences & Biomedicine
(184)
Humans
(166)
Male
(88)
Female
(85)
Middle Aged
(78)
Biological And Medical Sciences
(75)
Medical Sciences
(72)
Aged
(70)
Hematology
(65)
Adult
(63)
Animals
(40)
Tumors
(40)
Mice
(35)
Treatment Outcome
(34)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(32)
Cancer Research
(30)
Antineoplastic Agents
(28)
Pharmacology. Drug Treatments
(28)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Current clinical practice and outcome of neoadjuvant chemotherapy for early breast cancer: analysis of individual data from 94,638 patients treated in 55 breast cancer centers

Conventional chemotherapy (CHOEP-14) with rituximab or high-dose chemotherapy (MegaCHOEP) with rituximab for young, high-risk patients with aggressive B-cell lymphoma: an open-label, randomised, phase 3 trial (DSHNHL 2002-1)

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

Allogeneic transplantation in multiple myeloma: long-term follow-up and cytogenetic subgroup analysis

Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase

High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

Cetuximab plus oxaliplatin leucovorin 5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO)

Functional Analysis of Epidermal Growth Factor Receptor (EGFR) Mutations and Potential Implications for EGFR Targeted Therapy

Palonosetron improves prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: results of a double-blind randomized phase III trial comparing single doses of palonosetron with ondansetron

Positron Emission Tomography in Non–Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use

Results of a Phase III, Randomized, Placebo-Controlled Study of Sorafenib in Combination With Carboplatin and Paclitaxel As Second-Line Treatment in Patients With Unresectable Stage III or Stage IV Melanoma

The secondary FLT3-ITD F691L mutation induces resistance to AC220 in FLT3-ITD+ AML but retains in vitro sensitivity to PKC412 and Sunitinib

Surgery, brachytherapy, and external-beam radiotherapy for early prostate cancer

Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors

Randomized phase III study comparing irinotecan combined with 5-fluorouracil and folinic acid to cisplatin combined with 5-fluorouracil in chemotherapy naive patients with advanced adenocarcinoma of the stomach or esophagogastric junction

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model

Whole Pelvic Radiotherapy Versus Prostate Only Radiotherapy in the Management of Locally Advanced or Aggressive Prostate Adenocarcinoma

Split-dose docetaxel, cisplatin and leucovorin/fluorouracil as first-line therapy in advanced gastric cancer and adenocarcinoma of the gastroesophageal junction: results of a phase II trial

Phase II Study of Sunitinib Administered in a Continuous Once-Daily Dosing Regimen in Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

Cks1 is a critical regulator of hematopoietic stem cell quiescence and cycling, operating upstream of Cdk inhibitors

The Epidermal Growth Factor Receptor-L861Q Mutation Increases Kinase Activity without Leading to Enhanced Sensitivity Toward Epidermal Growth Factor Receptor Kinase Inhibitors

Aktive Filter

Suchergebnisse filtern